• Home  /
  • Research & Analysis   /
  • 2 Hot Wallstreet Cakes: Urban Outfitters Inc. (NASDAQ:URBN), Diplomat Pharmacy, Inc. (NYSE:DPLO)

2 Hot Wallstreet Cakes: Urban Outfitters Inc. (NASDAQ:URBN), Diplomat Pharmacy, Inc. (NYSE:DPLO)

Urban Outfitters Inc. (NASDAQ:URBN)

The shares of Urban Outfitters Inc. (NASDAQ:URBN) started off the last trading session with the price of $35.54 while closing the day with the price of $35.93. The shares of Urban Outfitters Inc. (NASDAQ:URBN) Rise 1.55% with the Gain of 0.39 points.

The shares of Urban Outfitters Inc. (NASDAQ:URBN) traded with the day volume of 1.89 Million shares whereas its average trading volume is 2.51 Million.

While analyzing the past performance of the stock we can see that the shares of Urban Outfitters Inc. (NASDAQ:URBN) Gain 0.14% in the last week while rising 0.08% in the last month. Past quarter performance shows the green light with 9.88%. The semi-annual and annual performance shows 57.8% and 49.9% respectively.

Some critical values of the shares of Urban Outfitters Inc. (NASDAQ:URBN) to be discussed here are: the beta which shows the value at 0.58 while Average True Range of Urban Outfitters Inc. (NASDAQ:URBN) demonstrate the value at 1.45. The weekly and monthly volatility of the shares of Urban Outfitters Inc. (NASDAQ:URBN) are indicated at 2.89% and 3.90%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 53.25.

While studying the financial position of the shares of Urban Outfitters Inc. (NASDAQ:URBN), we can see that the Market capitalization of the company is at 3.83 Billion. The shares outstanding for the company is 106.59 Million and the shares float stands at 68.72 Million. The income of the company stand at 173 Million while the sales stand at 3.62 Billion.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 1.56, Price to Earnings or P/E is at 23.11, Price to Sales P/S show the value of 1.06, the Return on Asset ROA stood at 0.09 and the Return on Equity ROE depicted at 0.132 while Return on Investment ROI is at 0.166.


Diplomat Pharmacy, Inc. (NYSE:DPLO)

Diplomat Pharmacy, Inc. (NYSE:DPLO) started its previous trading session at $22.41 and closed at $22.75 showing a Rise of 1.52 Percent.

The Company traded with an average Volume of 884.22 Million whereas, its Day Volume stood at 1.88 Million.

Looking at the performance of the stock, Diplomat Pharmacy, Inc. (NYSE:DPLO) Gain 1.52% in the last week in its shares price and -5.84% in the last month. Quarterly performance shows a green of 12.29 Percent while Semi-Annual and Annual performances shows a 16.73 and 45.18 percent respectively.

Beta for Diplomat Pharmacy, Inc. (NYSE:DPLO) stands at 1.33 while the ATR (average true range) is at 1.11. The Stock’s Weekly and Monthly Volatility is 3.05% and 5.09% respectively showing a RSI value of 49.67.

While studying the financial position of the shares of Diplomat Pharmacy, Inc. (NYSE:DPLO), we can see that the Market capitalization of the company is at 1.54 Billion. The shares outstanding for the company is 67.84 Million and the shares float stands at 48.62 Million.

The Company generated an income of 23.3 Million and the sales of 4.49 Billion in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $0.34 a share. P/E (price to earnings) and P/S (price to sales) values are 67.71 and 0.34 respectively.

The Return on Assets stands at 0.012, ROE shows a value of 0.023 and ROI for Diplomat Pharmacy, Inc. (NYSE:DPLO) is 0.023 as of Trailing Twelve Months period.

The following two tabs change content below.

Eldred Matthew

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a comment